AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Wanebo, H Chougule, P Ready, N Safran, H Ackerley, W Koness, RJ McRae, R Nigri, P Leone, L Radie-Keane, K Reiss, P Kennedy, T
Citation: H. Wanebo et al., Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer ofthe head and neck (stage III and IV), ANN SURG O, 8(8), 2001, pp. 644-650

Authors: Safran, H Gaissert, H Akerman, P Hesketh, PJ Chen, MH Moore, T Koness, J Graziano, S Wanebo, HJ
Citation: H. Safran et al., Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer, CANCER INV, 19(1), 2001, pp. 1-7

Authors: Safran, H Moore, T Iannitti, D Dipetrillo, T Akerman, P Cioffi, W Harrington, D Quirk, D Rathore, R Cruff, D Vakharia, J Vora, S Savarese, D Wanebo, H
Citation: H. Safran et al., Paclitaxel and concurrent radiation for locally advanced pancreatic cancer, INT J RAD O, 49(5), 2001, pp. 1275-1279

Authors: Safran, H Steinhoff, M Mangray, S Rathore, R King, TC Chai, L Berzein, K Moore, T Iannitti, D Reiss, P Pasquariello, T Akerman, P Quirk, D Mass, R Goldstein, L Tantravahi, U
Citation: H. Safran et al., Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma, AM J CL ONC, 24(5), 2001, pp. 496-499

Authors: Dupuy, DE Zagoria, RJ Akerley, W Mayo-Smith, WW Kavanagh, PV Safran, H
Citation: De. Dupuy et al., Percutaneous radiofrequency ablation of malignancies in the lung, AM J ROENTG, 174(1), 2000, pp. 57-59

Authors: Safran, H Wanebo, HJ Hesketh, PJ Akerman, P Ianitti, D Cioffi, W DiPetrillo, T Wolf, B Koness, J McAnaw, R Moore, T Chen, MH Radie-Keane, K
Citation: H. Safran et al., Paclitaxel and concurrent radiation for gastric cancer, INT J RAD O, 46(4), 2000, pp. 889-894

Authors: King, TC Akerley, W Fan, AC Moore, T Mangray, S Chen, MH Safran, H
Citation: Tc. King et al., p53 mutations do not predict response to paclitaxel in metastatic nonsmallcell lung carcinoma, CANCER, 89(4), 2000, pp. 769-773

Authors: King, TC Estalilla, OC Safran, H
Citation: Tc. King et al., Role of p53 and p16 gene alterations in determining response to concurrentpaclitaxel and radiation in solid tumors, SEM RAD ONC, 9(2), 1999, pp. 4-11

Authors: Safran, H Akerman, P Cioffi, W Gaissert, H Joseph, P King, T Hesketh, PJ Wanebo, H
Citation: H. Safran et al., Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction, SEM RAD ONC, 9(2), 1999, pp. 53-57

Authors: Chougule, PB Akhtar, MS Akerley, W Ready, N Safran, H McRae, R Nigri, P Bellino, J Koness, J Radie-Keane, K Wanebo, H
Citation: Pb. Chougule et al., Chemoradiotherapy for advanced inoperable head and neck cancer: A phase IIstudy, SEM RAD ONC, 9(2), 1999, pp. 58-63

Authors: Wanebo, HJ Chougule, P Ready, N Koness, RJ Akerley, W McRae, R Nigri, P Leone, L Webber, B Safran, H
Citation: Hj. Wanebo et al., Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV), SEM RAD ONC, 9(2), 1999, pp. 77-84
Risultati: 1-11 |